GEPER
Menu

About GEPER

Building the Future of Genomic Intelligence.

GEPER is a deep-tech company working at the intersection of genomics, computation, and artificial intelligence. We are early, ambitious, and building for the long term.

Why we exist

Genomes are being read far faster than they can be understood.

Sequencing stopped being the hard part. Interpretation did not. The distance between a genome that has been read and a genome that has been understood is where the field now loses most of its value — and it is the distance GEPER exists to close.

That is not a feature or a release. It is a decade-long scientific problem, and we are building a company shaped to work on it for that long.

What we stand for

Four commitments the company is built on.

  • We hold claims to the standard of evidence rather than the standard of demonstration. Where something cannot be assessed, we say so instead of quietly leaving it out.

  • We describe what our systems do and what they do not. A result that cannot show the reasoning behind it is not a result, and we would rather report uncertainty than hide it.

  • This work touches people’s lives. Expert judgement stays human: what we build is designed to support qualified reviewers, never to stand in for them.

  • We build on public science, open models and published standards, and we credit them. We would rather be right later than loud now.

Our ambition

To make biology legible to computation, and computation answerable to biology.

Both halves of that sentence matter. Biology has to be represented in a form computation can genuinely reason about; computation has to stay accountable to the biology it claims to explain. Most of the field is set up to do one or the other.

Our ambition is to be a company that can hold both at once — and, over time, one of the places where genomic intelligence is built, with the scientific standards, engineering discipline and patience that requires.

The long view

We are building for what comes next in biology.

If that is the kind of problem you work on — as a researcher, a clinician, a partner or an engineer — we would like to hear from you.